Search News
-
Published on May 20, 2025Source: The Economic Times - Pending
-
Published on May 20, 2025
Eris Lifesciences Q4 net profit Rises 28% to Rs102 crore, Eyes penfill insulin market
Mumbai: Eris Lifesciences reported a 28 per cent year-on-year rise in Q4 net profit to Rs102 crore, with revenues climbing to ₹705 crore. The company’s Profit After Tax went up 28.3 per cent on year-o-year (YoY) to ₹102 crore, while the PAT margin remained …
Source: ETPharma.com - Pending -
Published on May 20, 2025
The history of insulin usages for Type 1 diabetes
Hello again, dear readers, and welcome to a bonus letters column. This comes to you courtesy of the abundance of mail we have been receiving. We have a pair of interesting questions to cover, so let’s dive right in. • Diabetes has been a frequent topic in …
Source: Mankato Free Press - Minnesota - Pending -
Published on May 19, 2025
Domestic drug companies in a sweet spot as global players look beyond insulin
Leading Indian drugmakers such as Eris Lifesciences, Lupin, Mankind and Wockhardt are making strong inroads into the country's insulin market-long dominated by multinationals such as Novo Nordisk, Sanofi and Eli Lilly. A combination of investments in …
Source: The Economic Times - Pending -
Published on May 19, 2025
Record-breaking Insulin Safety Week unites over 800 healthcare sites
More than 800 healthcare sites across the UK and Ireland signed up to take part in last week’s Insulin Safety Week, marking a record-breaking year for the national campaign. The initiative once again placed a spotlight on the importance of insulin safety …
Source: The Diabetes Times - Neutral -
Published on May 19, 2025
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of ...
HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced the appointment of Michael Tung, M.D., MBA as Executive Vice President and Chief Financial Officer, effective …
Distribution channels: Companies, Technology ... -
Published on May 19, 2025
WCM-Q researchers probe links between insulin resistance and colorectal cancer
From right: Researchers Dr. Samson Mathews Samuel, Prof. Dr. Dietrich Büsselberg, and Elizabeth Varghese Doha, Qatar: Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have explored the possible links between insulin resistance and early-onset colorectal …
Source: The Peninsula - Gov't Propaganda -
Published on May 17, 2025
Ask the Doctors | The history of insulin usage for type 1 diabetes
Hello again, dear readers, and welcome to a bonus letters column. This comes to you courtesy of the abundance of mail we have been receiving. We have a pair of interesting questions to cover, so let's dive right in. • Diabetes has been a frequent topic …
Source: Cumberland Times-News - Maryland - Pending -
Published on May 17, 2025
Bucks County sues insulin makers, pharmacy benefit managers over insulin prices
Bucks County officials have filed a lawsuit against insulin makers and pharmacy benefit managers. "What we found is deeply troubling, a coordinated scheme between pharmacy benefit managers known as PBMs and manufacturers that has artificially inflated …
Source: WFMZ - Pennsylvania - Neutral -
Published on May 16, 2025
Diabetes Treatment Could Shift Focus From Insulin Resistance to Brain Activity
Register for free to listen to this article Thank you. Listen to this article using the player above. ✖ Want to listen to this article for FREE? Complete the form below to unlock access to ALL audio articles. Successfully treating type 2 diabetes may …
Source: Technology Networks - Neutral